Medication info
Losar 50 mg (Losartan Potassium)

Losar 50 mg (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
HanKook HyuTex Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200604178 · Approved 2006.05.04 · Insurance code 649100200

Summary

Main use
Treatment of hypertension and nephropathy in patients with type 2 diabetes with hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 to 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be administered orally in 2 divided doses per day, or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive medicine (e.g., a low dose of a diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Adults with nephropathy and type 2 diabetes with hypertension: The usual dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). No initial dose adjustment is necessary in elderly patients 75 years of age or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 to 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have intravascular volume depletion (e.g., patients receiving diuretic treatment), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents 6 years of age and older, weighing 20 kg or more but less than 50 kg, who can swallow tablets: The recommended dose is 25 mg of this medicine once daily; it may be increased to a maximum of 50 mg once daily depending on the patient's blood pressure response. Children and adolescents 6 years of age and older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily; it may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
HanKook HyuTex Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and nephropathy in patients with type 2 diabetes with hypertension

  • Hypertension
  • nephropathy in patients with type 2 diabetes
View approved original text

This medication helps lower blood pressure in patients with hypertension and is used especially for the prevention and treatment of nephropathy in patients with type 2 diabetes associated with hypertension. This treatment is effective for blood pressure control and kidney function protection.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 to 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be administered orally in 2 divided doses per day, or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive medicine (e.g., a low dose of a diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Adults with nephropathy and type 2 diabetes with hypertension: The usual dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). No initial dose adjustment is necessary in elderly patients 75 years of age or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 to 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have intravascular volume depletion (e.g., patients receiving diuretic treatment), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents 6 years of age and older, weighing 20 kg or more but less than 50 kg, who can swallow tablets: The recommended dose is 25 mg of this medicine once daily; it may be increased to a maximum of 50 mg once daily depending on the patient's blood pressure response. Children and adolescents 6 years of age and older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily; it may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. Patients with hypersensitivity to this drug, severe liver dysfunction, hereditary angioedema, primary hyperaldosteronism, etc., should not take this medication. Elderly patients, those with hyperkalemia, liver dysfunction, valvular heart disease, and renal impairment should use this drug cautiously, paying particular attention to prevent excessive blood pressure reduction. During treatment, blood pressure, kidney function, and electrolyte levels should be regularly monitored to ensure there are no abnormalities, and it is advisable to avoid concomitant use of potassium supplements or potassium-containing medications as hyperkalemia may occur. This drug can impact liver function; if symptoms of hepatitis appear, the physician should be consulted immediately, as serious hepatitis or renal failure can occur, requiring caution. Rapid drops in blood pressure may cause dizziness and shock symptoms; if these occur, the medication should be stopped immediately and medical advice obtained. Dizziness or drowsiness may occur during driving or operating machinery while taking this drug, so caution is required. This medication should not be used in children, especially those under 6 years of age, as its safety and efficacy have not been adequately established. Overdose may lead to hypotension and tachycardia, and appropriate emergency treatment may be necessary. It is not recommended for breastfeeding women, and if it must be taken, breastfeeding should cease. It is advisable to avoid grapefruit juice during treatment, and due to potential interactions with some medications, consultation with a physician or pharmacist is necessary if other medications are being taken.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorders
  • pharyngitis
Show 125 more
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • bloating
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • peeling of palm skin
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • appetite loss
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle stiffness
  • arthralgia
  • arthritis
  • fibromyalgia
  • muscle weakness
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory impairment
  • decreased libido
  • memory impairment
  • migraine
  • neurogenic pain
  • sensory anomalies
  • peripheral neuropathy
  • panic disorder
  • sleep disorders
  • hypersomnia
  • tremors
  • dizziness
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • thoracic discomfort
  • hair loss
  • dermatitis
  • dry skin
  • purpura
  • erythema
  • flushing
  • photosensitivity reaction
  • itching
  • rash
  • sweating
  • urticaria
  • blurred vision
  • burning sensation and pain in the eyes
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • visual impairment
  • erectile dysfunction
  • nocturia
  • polyuria
  • urethral infection
  • vascular edema
  • vasculitis
  • anaphylaxis-like syndrome
  • liver dysfunction
  • hepatitis
  • intestinal vascular edema
  • lethargy
  • elevated creatinine kinase
  • rhabdomyolysis
  • dry cough
  • erythema multiforme
  • hyponatremia
  • ALT elevation
  • increased BUN
  • increased serum creatinine
  • elevated liver enzymes
  • increased serum bilirubin
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular extrasystole
  • arrhythmia
  • hypoglycemia
  • weakness
  • hunger
  • cold sweat
  • tremors
  • decreased concentration
  • seizures
  • altered consciousness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture from entering and should be kept at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the drug's effectiveness.

Appearance and packaging

Appearance

White oval film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.